Banff 2016 Global Assessment and Quantitative Scoring for T Cell-Mediated Liver Transplant Rejection are Interchangeable

Table 2

Primary indications for transplant for adult patients who underwent liver transplantation in the study in 2015 and 2016 and the primary indications for transplant for adult patients from the cohort who were diagnosed with biopsy-proven T-cell mediated rejection (TCMR) within one year of transplantation.

Primary indication for transplant	N (total = 164)	Patients with TCMR N (total = 51)
Hepatitis C virus	39 (24%)	11 (21%)
Alcoholic cirrhosis	27 (16%)	11 (21%)
Hepatocellular carcinoma	17 (10%)	8 (16%)
Nonalcoholic fatty liver disease	17 (10%)	2 (4%)
Primary sclerosing cholangitis	15 (9%)	7 (14%)
Primary biliary cirrhosis	7 (4%)	1 (2%)
Hepatitis B virus	6 (4%)	0 (0%)
Autoimmune hepatitis	6 (4%)	2 (4%)
Subacute hepatic failure	6 (4%)	0 (0%)
Fulminant hepatic failure (drugs)	6 (4%)	7 (14%)
Others^∗	18 (11%)	2 (4%)

^∗Extrahepatic biliary atresia, alpha-1-antitrypsin deficiency, polycystic liver disease, Wilson’s disease, cryptogenic cirrhosis, haemangioendothelioma, hyperoxaluria type 1, hepatitis D virus.